La vendita allo scoperto per Vericel dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Vericel. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Vericel (NASDAQ:VCEL) Azioni, Report sulle vendite allo scoperto

VERICEL CORP

Vericel

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Vericel Corp

Trading Ideas

INHD

Inno Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Up 206.3%

Scotiabank analyst Greg Harrison maintains Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) with a Sector Outperform and lowers the price target from $52 to $51.

News

Price Target

Analyst Ratings

RCKT

Scotiabank Maintains Sector Outperform on Rocket Pharmaceuticals, Lowers Price Target to $51

RBC Capital analyst Nelson Ng maintains Algonquin Power (TSX:<a class="ticker" href="https://www.benzinga.com/stock/AQN#TSX">AQN</a>) with a Sector Perform and raises the price target from C$5.5 to C$6.

TSX:AQN

RBC Capital Maintains Sector Perform on Algonquin Power, Raises Price Target to C$6

RBC Capital analyst Nelson Ng maintains Algonquin Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AQN#NYSE">AQN</a>) with a Sector Perform and raises the price target from $5.5 to $6.

RBC Capital Maintains Sector Perform on Algonquin Power, Raises Price Target to $6

AMC Networks Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMCX#NASDAQ">AMCX</a>) on Friday reported a decline <a href="https://www.benzinga.com/quote/AMCX/earnings">in first-quarter sales.</a>
The company witnessed "continued pressure to core revenue streams," according to JPMorgan.&nbsp;
The AMC Networks Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5a281c52adcfa70001367bf2/david-karnovsky">Analyst David Karnovsky</a> maintained an Underweight rating, while reducing the price target from $8 to $6.
The AMC Networks Thesis: The company reported revenues and AOI (adjusted operating income) at $555 million and $104 million, missing estimates of $569 million and $108 million, respectively, Karnovsky said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
AMC Networks' domestic advertising declined by 15% in the quarter, which was not only worse than expected but also marked an acceleration from the 12% decline reported in the previous quarter, he added.
While reiterating their 2025 guidance, management indicated that there was "no noticeable impact on advertising from a macro perspective," while pointing to softness on the digital side, the analyst stated.
"The company was optimistic on streaming growth for the rest of the year which is reflective of benefits from rate increases, new series, and improved user engagement," he further wrote.
AMCX Price Action: Shares of AMC Networks had declined by 5.7% to $5.96 at the time of publication on Monday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/44019170/steve-madden-faces-looming-margin-pressure-and-tariff-headwinds-analyst-predicts-tough-road-ahead"> AMC Networks Does Not Gain Subscribers In Q1 And Profit Falls, Stock Slides</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Earnings Misses

Reiteration

Movers

AMCX

AMC Networks' Sales Drop As Analyst Warns Of 'Continued Pressure' On Revenue

Last week brought more &#8216;wait and see&#8217; from the FED. The central bank held rates as expected, citing the economy&#8217;s strength and attributing any recent indicator anomalies to tariff-induced swings in net exports.
The Fed&#8217;s stance fortified the US dollar, which reclaimed the key psychological level of 100 on the Dollar Index. It also helped support a rally in risk assets like stocks, which erased April&#8217;s decline entirely. The news also drove Asian currency moves, as the Japanese yen weakened late in the week. Risk-off mode drove investors into other currencies, notably the British pound.
The week ahead is relatively light on <a href="https://singaporeforexclub.com/how-to-read-the-forex-economic-calendar">news</a>, but those few items are impactful enough to make a big difference. Tuesday will bring the latest CPI news for the US dollar, while Australian unemployment and British GDP projections mark the second part of the week, alongside the latest US retail sales numbers. Powell&#8217;s speech on Thursday will provide additional clarification on the <a href="https://singaporeforexclub.com/macroeconomic-indicators-in-forex-trading">FED&#8217;s policy</a>, and any deviations from the tone set last Wednesday could drive volatility.
<h2 class="wp-block-heading">Key News:</h2>
<ul class="wp-block-list">
<li>Tuesday:&nbsp;USD— CPI, GBP—Governor Bailey Speech</li>
<li>Wednesday: AUD—Wage Price Index</li>
<li>Thursday: AUD—Unemployment, GBP—GDP, USD—Retail Sales, PPI, Powell Speech</li>
</ul>
<h2 class="wp-block-heading">Pairs In Focus</h2>
<h3 class="wp-block-heading">1. GBP SGD</h3>
GBP/SGD found a clear footing, forming a double bottom and failing to break to a lower low after a higher high in late April.
The level to look for is 1.73780 on the daily chart, about 100 pips above where the price closed on Friday.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="460" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12123222/GBPSGD_2025-05-11_22-08-24-1024x460.png" alt="" class="wp-image-12804" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12123222/GBPSGD_2025-05-11_22-08-24-1024x460.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12123222/GBPSGD_2025-05-11_22-08-24-300x135.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12123222/GBPSGD_2025-05-11_22-08-24-768x345.png 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12123222/GBPSGD_2025-05-11_22-08-24.png 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
GBP/SGD Daily Chart, Source: TradingView
If support at 1.71530 holds, a sustained push higher could take out the previous highs around 1.76.
<h3 class="wp-block-heading">2. CHF JPY</h3>
This pair has been forming a bullish pennant pattern on the daily chart, with a key level around 174.100, which is the middle of the formation.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="456" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12123231/CHFJPY_2025-05-11_22-10-26-1024x456.png" alt="" class="wp-image-12805" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12123231/CHFJPY_2025-05-11_22-10-26-1024x456.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12123231/CHFJPY_2025-05-11_22-10-26-300x134.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12123231/CHFJPY_2025-05-11_22-10-26-768x342.png 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/05/12123231/CHFJPY_2025-05-11_22-10-26.png 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
CHF/JPY Daily Chart, Source: TradingView
As long as price holds above this level on the daily chart, the price action should be bullish. It has the potential to take out the previous month&#8217;s high around 176.500 and move toward 177.400, around 250 <a href="https://singaporeforexclub.com/forex-pip-value-per-lot-size">pips</a> from current levels. Retail sentiment is 69% short, adding to the contrarian trade potential.
<h3 class="wp-block-heading">Notes:</h3>
<ul class="wp-block-list">
<li>AUD/NZD: Continues gaining bullish momentum. 1.09 is the level above the market to watch for.</li>
<li>AUD CAD: Remains in a ranging motion after fully erasing April's decline. The key support is around 0.88750, while resistance sits at 0.89750.</li>
<li>AUD/CHF: It is forming a bearish flag, with a possible support around 0.52800.</li>
<li>AUD/SGD: Saw a minor pullback higher, but it looks ready to continue the bearish momentum. Key resistance to watch is 0.84250.</li>
<li>AUD/JPY:&nbsp; Continues to retrace the significant decline from March. The key resistance level above the market is at 95.230.</li>
<li>CAD/JPY: After a fakeout lower, it recovered losses toward the end of the week. To clarify further bullish movement, it has to close above 105.</li>
<li>EUR/AUD: Tested the support below the market around 1.74300 but failed to break it. This level remains the key for further downside movement.</li>
<li>EUR JPY: Remains within the established support and resistance zone between 163.850 and 161.135.</li>
<li>EUR NZD: It stayed flat for the week and shows signs of further ranging price action.</li>
<li>GBP AUD: Pulled back higher, but ran into an intermediate resistance around 2.0600.</li>
<li>GBP NZD: Reversed after dipping early in the week, but closed below the key level of 2.25200.</li>
<li>NZD/JPY: The pair closed the week flat, but the overall bias is bullish, with a potential target of 87.330.</li>
</ul>
Note: Any opinions expressed in this article are not to be considered investment advice and are solely those of the authors. <a href="https://singaporeforexclub.com/">Singapore Forex Club</a> is not responsible for any financial decisions based on this article&#8217;s contents. Readers may use this data for information and educational purposes only.

Forex

Opinion

Risk-Off Mode Could Spur Further Yen Decline

<a href="https://www.cnmv.es/webservices/verdocumento/ver?t=%7Bb75ee6db-df80-49ee-bf19-dfb0c0eed666%7D" title="https://www.cnmv.es/webservices/verdocumento/ver?t=%7Bb75ee6db-df80-49ee-bf19-dfb0c0eed666%7D">https://www.cnmv.es/webservices/verdocumento/ver?t=%7Bb75ee6db-df80-49ee-bf19-dfb0c0eed666%7D</a>

Biotech

Earnings

Guidance

Global

General

GRFS

Grifols Q1 Revenue €1.786 Billion; Adjusted EBITDA €400 Million; Q1 Net Income €60 Million; Confirms 2025 Guidance; Says On Track To Launch Fibrinogen In Europe In Q4'25 And In The U.S. In H1'26, Following FDA Approval; Expects To Share Greater Detail In 2025 Due To Impact Of Inflation Reduction Act On Its Financial Results

Scotiabank analyst Greg McGinniss maintains Rexford Industrial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REXR#NYSE">REXR</a>) with a Sector Perform and lowers the price target from $39 to $37.

REXR

Scotiabank Maintains Sector Perform on Rexford Industrial Realty, Lowers Price Target to $37

BJ's Wholesale Club Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) has outperformed the market over the past 5 years by 16.13% on an annualized basis producing an average annual return of 31.26%. Currently, BJ's Wholesale Club Hldgs has a market capitalization of $14.98 billion. 
Buying $100 In BJ: If an investor had bought $100 of BJ stock 5 years ago, it would be worth $387.93 today based on a price of $113.76 for BJ at the time of writing.
<h3>BJ's Wholesale Club Hldgs's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747064722_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning BJ's Wholesale Club Hldgs Stock In The Last 5 Years

According to financial guru Ramit Sethi, there are <a href="https://www.youtube.com/watch?v=7dN6_bZDhDk">seven levels of wealth</a>. Once you get into the fourth level, things get pretty exciting. This "Growth" stage is when your money works harder than you.
Sethi shared strategies you can use to reach this level, plus how you can advance to the final three levels of building wealth. However, he said that people who are in growth mode typically have these two details in common.
"You think in percentages and strategy," Sethi stated in the video.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
Percentages are important when it comes to investing, knowing the percentage of money you keep, and setting long-term goals. Strategies can help you turn your goals into realities. Here's how thinking in percentages and strategy can boost your finances.
<h2 class="wp-block-heading">Be Highly Intentional With Your Money</h2>
People who are in growth mode are highly intentional with their money. They carefully consider every expense and how their daily actions move them closer to their long-term goals.&nbsp;
Percents and strategy both play a role in conscious financial management. Sethi suggests increasing your annual portfolio contributions by 1% each year. For instance, if you contribute 15% of your paycheck to your portfolio, Sethi believes you should bump it up to 16% next year.
This level of intentionality makes it easier for wealth to build on itself. You are already making consistent investments at the growth level.
Trending: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
<h2 class="wp-block-heading">Make Healthy Trade-Offs To Grow Your Wealth</h2>
Trade-offs are a part of life. You have to say no to some people or opportunities to say yes to other people and opportunities. Any time you say yes to something, you automatically say no to anything else during that time frame.&nbsp;
You can make certain trade-offs that minimize your expenses so you can build your wealth faster. For instance, you may have some unused subscriptions that continue to rack up debt. Getting rid of these subscriptions and removing other unnecessary costs can move you closer to your long-term goals.
However, Sethi isn't an advocate for penny-pinching for your entire life. He believes in spending money on things that bring you the most happiness. Trading off the expenses that don't make you as happy will free up money you can use on the expenses that bring you more happiness.
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
<h2 class="wp-block-heading">Use A Compound Interest Calculator</h2>
Sethi encourages his viewers to use a compound interest calculator to map out how much their wealth can compound in the long run. You can enter your current net worth and see how an annualized 8% return will affect your wealth over the next 10, 20, and 30 years. Sethi recommends using those time frames in your calculations.
Compound interest calculators can give you more momentum and help you ramp up your investments. These calculators also let you see how small increases to your monthly portfolio contributions can have a big impact on your long-term wealth.&nbsp;
Read Next:
<ul class="wp-block-list">
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Ramit Sethi Identifies Two Key Traits Of People Who Are Growing Their Finances: 'You Think In Percentages And Strategy'

Scotiabank analyst Nicholas Yulico maintains Regency Centers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REG#NASDAQ">REG</a>) with a Sector Perform and lowers the price target from $76 to $75.

Scotiabank Maintains Sector Perform on Regency Centers, Lowers Price Target to $75

RBC Capital analyst Ken Herbert reinstates AeroVironment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) with a Outperform and announces $190 price target.

Initiation

AVAV

RBC Capital Reinstates Outperform on AeroVironment, Announces $190 Price Target

Scotiabank analyst Nicholas Yulico maintains Realty Income (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>) with a Sector Perform and raises the price target from $57 to $58.

Scotiabank Maintains Sector Perform on Realty Income, Raises Price Target to $58

Surgery Partners Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRY#NASDAQ">SGRY</a>) reported first-quarter adjusted earnings of 4 cents per share on Monday, lower than the 10 cents reported a year ago, missing the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of 5 cents</a>.
Surgery Partners is a healthcare services company focused on surgical services. It has over 200 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45344198/surgery-partners-inc-announces-first-quarter-2025-results-reaffirms-full-year-2025-guidance" rel="noreferrer noopener">and urgent care facilities</a>.
The company reported quarterly sales of $776 million, compared to $717.4 million for the first quarter of 2024, missing the consensus of $777.07 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/45007148/hospital-chain-hca-healthcare-clocks-q1-profit-of-16-billion-on-stronger-volume-says-unchanged-annual-guidance-includes-tariff-impact" rel="noreferrer noopener">HCA Healthcare Shows Strong Pulse In Q1, Keeps 2025 Outlook Healthy</a>
Same-facility revenues for the first quarter of 2025 increased 5.2% compared to the same period in the prior year, with a (1.2)% decrease in revenue per case and a 6.5% increase in same-facility cases.
For the first quarter of 2025, adjusted EBITDA was $103.9 million, compared to $97.5 million for the same period in 2024.
Surgery Partners had cash and cash equivalents of $229.3 million and $388.9 million of borrowing capacity under its revolving credit facility as of March 31.
Cash flows from operating activities were $6.0 million for the first quarter of 2025, compared to $40.7 million for the same period in 2024.
At the end of the first quarter of 2025, the company&#8217;s ratio of total net debt to EBITDA, as calculated under its credit agreement, was approximately 4.1x.
2025 Outlook: Surgery Partners reaffirmed its 2025 outlook.
The company expects sales of $3.30 billion-$3.45 billion versus the consensus of $3.39 billion.
The company sees adjusted EBITDA of $555&nbsp;million-$565&nbsp;million.
Eric Evans, CEO, stated, &#8220;Our continued focus on maximizing portfolio performance, advancing a robust M&amp;A pipeline, and driving greater operating efficiencies, combined with a bullish outlook on surgical trends and the regulatory landscape, have us positioned to continue delivering industry-leading earnings growth in 2025 and beyond.&#8221;
Dave Doherty, CFO, says Surgery Partners has sufficient liquidity and cash generated from operations &#8220;to fund future M&amp;A activity at levels that support our long-term growth objectives without having to access incremental capital from the debt or equity markets over the next five years.&#8221;
Surgery Partners received a non-binding proposal from Bain Capital Private Equity in January for a cash <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1638833/000110465925006658/tm254726d1_ex99-1.htm" rel="noreferrer noopener">consideration of $25.75 per share</a>.
Price Action: SGRY stock is down 2.29% at $22.16 at the last check on Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/biotech/25/05/45347237/novo-nordisks-sogroya-supports-effective-weekly-alternative-to-daily-hormone-therapy-across-three-growth-disorders" target="_blank" rel="noreferrer noopener">Novo Nordisk&#8217;s Sogroya Supports Effective Weekly Alternative To Daily Hormone Therapy Across Three Growth Disorders</a></li>
</ul>
Image: Shutterstock

Health Care

SGRY

Surgery Partners Misses Q1 Marks But Sticks To 2025 Outlook

Scotiabank analyst Nicholas Yulico maintains Public Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSA#NYSE">PSA</a>) with a Sector Outperform and raises the price target from $305 to $340.

Scotiabank Maintains Sector Outperform on Public Storage, Raises Price Target to $340

Scotiabank analyst Nicholas Yulico maintains Prologis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLD#NYSE">PLD</a>) with a Sector Underperform and raises the price target from $97 to $100.

Scotiabank Maintains Sector Underperform on Prologis, Raises Price Target to $100

RBC Capital analyst Matthew Swanson maintains Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) with a Outperform and raises the price target from $13 to $14.

NEXN

RBC Capital Maintains Outperform on Nexxen International, Raises Price Target to $14

Scotiabank analyst Brandon Bingham maintains Plains All American (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NASDAQ">PAA</a>) with a Sector Outperform and lowers the price target from $21 to $20.

Scotiabank Maintains Sector Outperform on Plains All American, Lowers Price Target to $20

Scotiabank analyst Phil Hardie maintains Onex (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ONEX#TSX">ONEX</a>) with a Sector Outperform and raises the price target from C$130 to C$132.

TSX:ONEX

Scotiabank Maintains Sector Outperform on Onex, Raises Price Target to C$132

Scotiabank analyst Nicholas Yulico maintains Mid-America Apartment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAA#NYSE">MAA</a>) with a Sector Outperform and raises the price target from $182 to $194.

Comments

Vericel

Vendite allo scoperto

Vericel (NASDAQ:VCEL) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO